Exxon Mobil Corp
Change company Symbol lookup
Select an option...
XOM Exxon Mobil Corp
AMRC Ameresco Inc
ET Energy Transfer LP
AHCO Adapthealth Corp
LPSN LivePerson Inc
BGSF BGSF Inc
NEE Nextera Energy Inc
PSB-Y PS Business Parks Inc
ADBE Adobe Inc
APWL Advanced Powerline Technologies Inc
Go

Energy : Oil, Gas & Consumable Fuels | Large Cap Value
Company profile

Exxon Mobil Corporation is engaged in energy business. The Company is engaged in the exploration, production, trade, transportation and sale of crude oil and natural gas, and the manufacture, transportation and sale of crude oil, natural gas, petroleum products, petrochemicals and a range of specialty products. The Company's segments include Upstream, Downstream, Chemical, and Corporate and Financing. The Upstream segment operates to explore for and produce crude oil and natural gas. The Downstream manufactures, trades and sells petroleum products. The refining and supply operations consists of a global network of manufacturing plants, transportation systems, and distribution centers that provide a range of fuels, lubricants and other products and feedstocks to its customers around the world. The Chemical segment manufactures and sells petrochemicals. The Chemical business supplies olefins, polyolefins, aromatics, and a variety of other petrochemicals.

Premarket

Last Trade
Delayed
$61.69
0.41 (0.67%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$61.28
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
4,355

10-day average volume:
23,847,903
4,355

AbbVie Inc. Stock Outperforms Market On Strong Trading Day

4:33 pm ET September 29, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) rose 1.40% to $108.84 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.16% to 4,359.46 and the Dow Jones Industrial Average rising 0.26% to 34,390.72. AbbVie Inc. closed $12.69 below its 52-week high ($121.53), which the company reached on September 1st.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Pfizer Inc. (PFE) rose 1.14% to $43.53, Eli Lilly & Co. (LLY) rose 3.95% to $230.36, and AstraZeneca PLC ADR (AZN.LN) rose 3.54% to $59.67. Trading volume (6.3 M) remained 891,318 below its 50-day average volume of 7.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

September 29, 2021 16:33 ET (20:33 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.